NHS Starts Blood Test Trial to Detect More Than 50 Types of Cancer
The NHS-Galleri Trial is being launched to evaluate whether a blood test may help identify cancer earlier when combined with
Read moreThe NHS-Galleri Trial is being launched to evaluate whether a blood test may help identify cancer earlier when combined with
Read moreThe global leader in serving science, Thermo Fisher Scientific has announced that the U.S. Food and Drug Administration (FDA) has
Read moreNovel lipases of microbial origin selected and engineered for best performance. A EUCODIS Bioscience Case Study EUCODIS Bioscience offers a
Read moreThe Recombinant TEV Protease Protein His6 is a genetically optimised 28 kDa variation of the N1a protease from tobacco etch
Read moreThe novel AUMED test kit RT-LAMP Assay SARS-CoV2 developed for diagnostics of the SARS-CoV-2 virus can be used for detection
Read moremyPOLS Biotec has developed a real-time 5x Multiplex qPCR Master Mix which is optimised for robust and reproducible PCR performance.
Read moreThe main protease (Mpro) is a key enzyme of SARS-CoV-2 and is required for viral replication and transcription. A Biosynth
Read moreQIAGEN officially confirmed a global cooperation agreement with Sysmex Corporation for the development and commercialization of cancer companion diagnostics, leveraging
Read moreNucleai and Merck KGaA will collaborate utilizing Nucleai’s AI-powered platform to develop pathology-based biomarkers as companion diagnostics. Nucleai, a precision
Read moreSingle-step purification and optimized reaction chemistry enable SARS-CoV-2 PCRwithin ~70 minutes. A BioEcho Life Sciences Case Study Laboratory-based polymerase chain
Read more